Echo Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
05 Jan 2016	Form 3: Edelman Elazer R, Director No securities owned
07 Jan 2015	Form 3: Schoenbart Alan Wayne, CFO and Secretary
07 Jan 2015	Form 3: Hollander Scott Wayne, Director
30 Jul 2014	Form 3: Bernhardt Charles Thomas Iii, Interim CFO No securities owned
14 Jul 2014	Form 3: Goldberg Shepard M, Director No securities owned
10 Mar 2014	Form 3: Goldberg Michael M, Director Holds 39,800 shares of Common Stock
22 Jul 2013	Form 3: Platinum Partners Value Arbitrage Fund, Lp, 10% owner and 6 others Holds 452,169 shares of Common Stock
14 Mar 2013	Form 3: Doman Robert F, Director No securities owned
14 Oct 2011	Form 3: Burke Kimberly A, General Counsel Holds 175,000 shares of Common Stock
17 May 2011	Form 3: Schnittker Christopher P., CFO No securities owned
17 Feb 2011	Form 3: Smith James Francis, Director Holds 7,000 shares of Common Stock
17 Feb 2011	Form 3: Grieco William, Director Holds 150,000 shares of Common Stock
27 Mar 2008	Form 3: Enright Vincent D, Director Holds 0 shares of No securities are beneficially owned
19 Sep 2007	Form 3: Cato Holding Co, 10% owner Holds 3,855,225 shares of Common Stock
19 Sep 2007	Form 3: Cato Allen Easley, 10% owner Holds 113,389 shares of Common Stock
17 Sep 2007	Form 3: Mooney Patrick T, Director No securities owned
17 Sep 2007	Form 3: Singh Shawn, Director No securities owned
16 Feb 2007	Form 3: Witoshkin Walter W, Director Holds 50,000 shares of Common Stock
29 Jun 2006	Form 3: Mitchell Harry, Interim CFO No securities owned
25 May 2005	Form 3: Marston Barry, VP of Sales & Marketing Holds 9,279 shares of Common Stock

Comments